Picture of WW International logo

WW — WW International News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapTurnaround

WW International Q1 revenue falls

Overview

Weight management platform's fiscal Q1 revenue fell yr/yr

Adjusted EPS for fiscal Q1 missed analyst expectations

Company reaffirmed 2026 guidance and will reduce debt by $42 mln

Outlook

WW International reaffirms 2026 revenue guidance of $620 mln to $635 mln

Company maintains 2026 adjusted EBITDA guidance of $105 mln to $115 mln

Result Drivers

CLINICAL GROWTH - Q1 Clinical Subscription Revenue rose 32% yr/yr and Clinical Subscribers grew 46% yr/yr, despite lapping prior year growth from former compounded semaglutide offering

BEHAVIORAL DECLINE - Behavioral Subscription Revenue fell 18% yr/yr, with company citing secular headwinds in Core membership tier

HIGHER-VALUE TIERS - Q1 ARPU increased 13% yr/yr, reflecting a continued mix shift towards higher ARPU Med+ and Core+ membership tiers

Company press release: ID:nGNX13TGfr

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueBeat$168 mln$158.55 mln (2 Analysts)
Q1 EPSMiss-$5.20-$2.45 (3 Analysts)
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on WW International

See all news